Neurophysiological studies suggest that anaesthetic agents depress synaptic transmission by reducing neurotransmitter release with axonal conduction remaining relatively unaffected. [1] [2] [3] While there is good agreement that neurotransmission is reduced, the precise cellular mechanisms(s) remains to be fully elucidated. At clinically relevant concentrations, anaesthetic agents (with the exception of ketamine) interact with GABA A receptors to increase Cl 9 conductance and produce hyperpolarization, suggesting that this may be a common target site for all anaesthetic agents. 4 5 However, at variance with this hypothesis is the observation that some anaesthetics inhibit the release of GABA. 6 7 While the GABA hypothesis is extremely attractive, it is premature to discount other potential target site(s). One such target is the voltage-sensitive Ca 2; channel and there has been much debate as to its importance in general anaesthesia. 5 8 9 As the presynaptic regulation of neurotransmitter release is, in general, a Ca 2; -dependent process, 10 closing of presynaptic voltage-sensitive Ca 2; channels seems a logical mechanism for inhibition of transmitter release. Such a mechanism (with hyperpolarization) is used by opioid receptors. 11 12 We have demonstrated previously that release of . 13 
For K
; the response is extracellular Ca 2; dependent whereas for carbachol the response in extracellular Ca 2; independent. 13 Purkiss, Nahorski and Willars have also demonstrated in this cell line that muscarinic stimulation of release used Ca 2; from the inositol (1,4,5) triphosphate (Ins(1,4,5)P 3 ) sensitive store 14 and muscarinic receptor stimulation is known to produce a substantial biphasic increase in Ins(1,4,5)P 3 mass in these cells. 15 16 While we are not claiming that the release of noradrenaline per se is involved in the anaesthetic state we have used the well defined characteristics of the release process to probe the site(s) of action of a range of anaesthetics, including thiopentone, propofol 17 and ketamine. 18 In this study using SH-SY5Y cells, we report that the volatile general anaesthetic agent, halothane, selectively inhibited K ; evoked noradrenaline release suggesting that this agent inhibited Ca 2; entry through voltage-sensitive Ca 2; channels.
Materials and methods

CELL CULTURE AND BUFFERS
SH-SY5Y cells, passages 70-90, were maintained in minimum essential medium supplemented with penicillin 100 u. ml
91
, streptomycin 100 g ml 91 , fungizone 2.5 g ml 91 and 10% fetal calf serum. Halothane was delivered to the buffer reservoir using a pre-calibrated Fluotec agent specific vaporizer with humidified air as the carrier gas. The humidifier was positioned after the vaporizer. Vaporizer settings of 1-5 atm% were used (in random order) and air was the control. Halothane was perfused from saturated solutions for 15 min either between S 1 and S 2 (for K ; ) or during the final 15-min buffer perfusion (for carbachol). Aqueous halothane concentrations were measured in both the reservoir and at the perfusion chamber outlet (see below). MEASUREMENT ] i was measured fluorimetrically using a Perkin-Elmer LS50B fluorimeter with excitation wavelengths set at 340 and 380 nm; emission was measured at 510 nm. SH-SY5Y cell suspensions were incubated with Fura2AM 3 mol litre 91 for 30 min at 37 ЊC and then post-incubated with fresh buffer for another 20 min at room temperature to allow for complete ester hydrolysis. 20 Loaded cells (200 l) were placed into a cuvette containing 1.8 ml of buffer, pre-equilibrated for 15 min with halothane (vaporizer setting 0.75, 1.5 and 3.0 atm% in random order) via "surface blowing". After another 3 min of gassing, the cells were exposed to either K ; 80 mmol litre 91 or carbachol 1 mmol litre 91 in the continued presence of halothane or air. Excitation ratio measurements (340/380) were obtained every 1 s and converted to [Ca ] i according to Grynkiewicz, Poenie and Tsien 21 where maximum (Rmax) and minimum (Rmin) fluorescence ratios were estimated using 0.1% Triton X and EGTA 4.5 mmol litre 91 , respectively. Halothane did not affect the fluorescence properties of Fura2. Aqueous halothane concentrations were measured in the cuvette (see below).
MEASUREMENT OF AQUEOUS HALOTHANE CONCENTRATIONS
Buffer halothane concentrations were measured by gas chromatography according to Rutledge and colleagues. 22 After equilibration for various times at various vaporizer settings, 100 l of buffer was injected rapidly to sealed glass vials containing 
Discussion
We have demonstrated that the volatile general anaesthetic halothane produced a dose-dependent , respectively) agree well with clinically relevant concentrations for this agent. 23 A clinical estimate of IC 50 is the minimum alveolar concentration (MAC) of agent that inhibits movement to skin incision in 50% of patients; for halothane this is 0.75 atm%. 23 However, while this value agrees well with our data for significant inhibition, extrapolation of MAC (for a whole organism) to measurements made with isolated neuronal cells is difficult, and should be undertaken carefully.
In SH-SY5Y cells, depolarization with high doses of K ; produces an increase in Ca 2; influx through both L-and N-type voltage-sensitive Ca 2; channels measured in Fura2 loaded cells. 24 In addition, the existence of these channels has been demonstrated electrophysiologically, although L channels are likely to be expressed at low levels. 25 Indeed, we have noted that SH-SY5Y cells express low levels of L-type VSCC (:10 fmol/mg protein [ ). This study gives no indication of which channel (L, N or both) is inhibited by halothane. For carbachol, the increase in intracellular Ca 2; was biphasic with the peak phase representing release of Ca 2; from an Ins(1,4,5)P 3 sensitive store and the plateau phase representing Ca 2; influx through a receptor operated Ca 2; channel. 27 28 The time course for generation of Ins(1,4,5)P 3 was also biphasic showing a close temporal (and dose) relationship. 15 16 Our data clearly showed that muscarinic agonist increased intracellular [Ca Volatile anaesthetics have been shown to inhibit the release of a variety of neurotransmitters from various tissues. 2 Halothane inhibits the release of catecholamines from bovine adrenal chromaffin cells at clinically relevant concentrations in response to carbachol (presumably acting at nicotinic receptors in this preparation) but not depolarization. 29 30 Similar findings have also been reported for enflurane, isoflurane and methoxyflurane. 30 In our study we found the opposite effect, with K ; but not carbachol evoked release being reduced. This may result from muscarinic M 3 receptors coupling to release in SH-SY5Y cells and nicotinic receptors coupling to release in chromaffin cells. However, it should also be noted that some batches of SH-SY5Y cells express nicotinic receptors and nicotine has been shown to increase intracellular Ca Halothane and isoflurane inhibited K ; evoked catecholamine secretion and increase in intracellular Ca 2; through L-type VSCC from PC12 cells at clinically relevant concentrations. 36 In addition to these reported inhibitory effects of volatile anaesthetics, stimulatory effects have also been reported; for example, halothane, enflurane, isoflurane and methoxyflurane enhanced phorbol ester evoked catecholamine release from PC12 cells. 41 42 44 and inhibiting release of Ca 2; from intracellular stores. 43 44 However, while there are many studies of the effects of volatile agents on Ca 2; homeostasis, the role of this divalent cation in the mechanisms of general anaesthesia still remains controversial, especially with respect to VSCC activity. 5 8 9 In addition, the potency of halothane for the production of anaesthesia in humans displays a steep curve, with MAC:0.75 atm%, 5 whereas inhibition of VSCC in this study showed a more shallow curve. We feel that the comparison of dose-related effects of halothane on VSCC activity with estimation of MAC in a population of subjects should be made with caution. 45 There are few reports of the effects of volatile anaesthetic agents on phosphoinositide hydrolysis. 46 47 We have measured Ins(1,4,5)P 3 mass formation in response to halothane and isoflurane in SH-SY5Y cells and reported dose-dependent (EC 50 for halothane at 0.75 atm%) enhancement of carbachol stimulated Ins(1,4,5)P 3 formation. 47 In addition, basal Ins(1,4,5)P 3 formation was also enhanced. These data are at variance with the lack of effect of halothane on basal or carbachol stimulated increase in intracellular Ca 2; and [ 3 H]noradrenaline release. However, the increase in Ins(1,4,5)P 3 formation was relatively small in comparison with the increase produced by carbachol.
In summary, we have shown that halothane, at concentrations which produce general anaesthesia, inhibited depolarization (but not muscarinic agonist) evoked release of [ 3 H]noradrenaline by reducing Ca 2; influx through VSCC. These data are in general agreement with our previous findings for propofol, thiopentone 17 and ketamine 18 and adds weight to our hypothesis that VSCC may be a target site for anaesthetic agents. Clearly, this hypothesis will need further rigorous testing.
